ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

SPNC The Spectranetics Corp. (MM)

38.45
0.00 (0.00%)
After Hours
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
The Spectranetics Corp. (MM) NASDAQ:SPNC NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 38.45 38.45 38.50 0 01:00:00

IMPORTANT SHAREHOLDER DEADLINE: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit Against The Spect...

29/08/2015 1:56am

Business Wire


The Spectranetics Corp. (MM) (NASDAQ:SPNC)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more The Spectranetics Corp. (MM) Charts.

Khang & Khang LLP (the “Firm”) announces that a class action lawsuit has been filed in the United States District Court for the District of Colorado against The Spectranetics Corporation (“Spectranetics” or the “Company”) (NASDAQ: SPNC). Investors who purchased or otherwise acquired shares between February 19, 2015, and July 23, 2015, inclusive (the “Class Period”) are encouraged to contact the Firm immediately to discuss their legal options.

If you purchased shares of Spectranetics during the class period, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or by email at joon@khanglaw.com.

There has been no class certification in this case. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

Spectranetics manufactures and sells medical devices used in cardiovascular surgery. The complaint against Spectranetics alleges that: (1) increasing competition had adversely affected the Company; (2) that Spectranetics' sales force optimization efforts were not adequate and caused the Company to perform below expectations; and (3) that the Company lacked adequate internal controls. On July 23, 2015, Spectranetics reported results that fell below Wall Street’s expectations. The Company attributed the lowering of its guidance to competitive drug-coated balloon launches and ongoing sales team optimization. When this news was revealed to investors, shares fell by approximately 34%, to close at $24.83 per share.

If you purchased shares of Spectranetics during the Class Period you have until October 26, 2015 to ask the Court to appoint you as lead plaintiff. If you wish to learn more about this lawsuit, or if you have any questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or by email at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

KHANG & KHANG LLPJoon M. Khang, Esq.Telephone: 949-419-3834Facsimile: 949-225-4474joon@khanglaw.com

1 Year The Spectranetics Corp. (MM) Chart

1 Year The Spectranetics Corp. (MM) Chart

1 Month The Spectranetics Corp. (MM) Chart

1 Month The Spectranetics Corp. (MM) Chart

Your Recent History

Delayed Upgrade Clock